Hemolytic anemia: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:
Signs of [[anemia]] are generally present ([[Fatigue (physical)|fatigue]], later [[heart failure]]).  Jaundice may be present.
Signs of [[anemia]] are generally present ([[Fatigue (physical)|fatigue]], later [[heart failure]]).  Jaundice may be present.
*certain aspects of the medical history can suggest a cause for hemolysis (drugs, [[fava bean]] or other sensitivity, [[heart valve prosthesis|prosthetic heart valve]], or another medical illness)
*certain aspects of the medical history can suggest a cause for hemolysis (drugs, [[fava bean]] or other sensitivity, [[heart valve prosthesis|prosthetic heart valve]], or another medical illness)
Clinical findings in haemolytic anaemias:
# increased serum [[bilirubin]] levels in blood, therefore [[jaundice]]
# pallor in mucous membrane and skin
# increased urobilinogen in urine. urine turns dark on standing
# [[Splenomegaly]]
# Pigmented [[gallstone]]s may be found


==Classification of hemolytic anaemias==
==Classification of hemolytic anaemias==

Revision as of 16:22, 28 August 2012

Hemolytic anemia
Bone Marrow: Leukoerythroblastic Reaction and Microangiopathic Hemolytic Anemia in a Patient with Bone Marrow Metastasis
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10 D55-D59
ICD-9 282, 283, 773
DiseasesDB 5534
MedlinePlus 000571

Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia

CDC on Hemolytic anemia

Hemolytic anemia in the news

Blogs on Hemolytic anemia

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia

For patient information on this, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Haemolytic anaemia

Overview

In a healthy person, a red blood cell survives 90 to 120 days (on average) in the circulation, so about 1% of human red blood cells break down each day. The spleen (part of the reticulo-endothelial system) is the main organ which removes old and damaged RBCs from the circulation. In health the break down and removal of RBCs from the circulation is matched by the production of new RBCs in the bone marrow.

When the rate of breakdown increases, the body compensates by producing more RBCs, but if compensation is inadequate clinical problems can appear. Breakdown of RBCs can exceed the rate that the body can make RBCs and so anemia can develop. The breakdown products of hemoglobin will accumulate in the blood causing jaundice and be excreted in the urine causing the urine to become dark brown in colour.

Symptoms

Signs of anemia are generally present (fatigue, later heart failure). Jaundice may be present.

  • certain aspects of the medical history can suggest a cause for hemolysis (drugs, fava bean or other sensitivity, prosthetic heart valve, or another medical illness)

Classification of hemolytic anaemias

Template:Hematology

ar:فقر الدم التحللي de:Hämolytische Anämie sr:Хемолитичка анемија

Template:WikiDoc Sources